Quadrature Capital LTD Reviva Pharmaceuticals Holdings, Inc. Transaction History
Quadrature Capital LTD
- $4.51 Trillion
- Q1 2025
A detailed history of Quadrature Capital LTD transactions in Reviva Pharmaceuticals Holdings, Inc. stock. As of the latest transaction made, Quadrature Capital LTD holds 38,941 shares of RVPH stock, worth $15,965. This represents 0.0% of its overall portfolio holdings.
Number of Shares
38,941Holding current value
$15,965% of portfolio
0.0%Shares
2 transactions
Others Institutions Holding RVPH
# of Institutions
58Shares Held
8.04MCall Options Held
938KPut Options Held
40.8K-
Vanguard Group Inc Valley Forge, PA1.8MShares$739,6770.0% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny1.53MShares$629,0690.0% of portfolio
-
Diadema Partners LP Morristown, NJ651KShares$266,7960.16% of portfolio
-
Persistent Asset Partners LTD Hong Kong, K3641KShares$262,8810.18% of portfolio
-
Tang Capital Management LLC San Diego, CA510KShares$209,2340.03% of portfolio
About REVIVA PHARMACEUTICALS HOLDINGS, INC.
- Ticker RVPH
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 20,442,900
- Market Cap $8.38M
- Description
- Reviva Pharmaceuticals Holdings, Inc., a clinical-stage biopharmaceutical company, discovers, develops, and commercializes next-generation therapeutics for diseases targeting unmet medical needs in the areas of central nervous system, respiratory, cardiovascular, metabolic, and inflammatory diseases. The company's lead product candidate is RP506...